The HIV/AIDS Channel
Vitamin and Mineral Supplements Given Early in HIV Infection Can Help Improve Immunity and Slow Disease Progression
HIV/AIDS
HIV infection attacks the immune system. In many parts of Africa, patients with HIV infection, also have vitamin deficiencies. A new study examined whether giving a multivitamin and…
Infrared Coagulation Controls Anal Neoplasia in HIV
HIV/AIDS
NEW YORK (Reuters Health) – In HIV patients with anal intraepithelial neoplasia (AIN), infrared coagulation (IRC) helps avoid progression to squamous cell carcinoma (SCC), Spanish doctors say. “High-grade…
Recent Videos in HIV/AIDS
New Interferon-Free Medications Successfully Treat Hepatitis C in Patients with HIV
Hepatitis C Content Hub
Today there are more highly effective treatments for patients with HIV. However, these patients can also have higher rates of hepatitis C infection. Even though the HIV is…
Second Dose of Meningococcal Vaccine Improves Response Rates in HIV-infected Youth
Family Medicine
NEW YORK (Reuters Health) – A second dose of quadrivalent meningococcal conjugate vaccine (MCV4) 6 months after the first dose significantly improves response rates in youth infected with…
Fewer Adults Dying in African Countries That Received US Financial Support for AIDS Relief
HIV/AIDS
Treatment, education and prevention have been the focus of the United States when it comes to addressing the HIV/AIDS epidemic in Africa. In 2003, the President’s Emergency Plan…
Increased risk of sudden cardiac death with HIV infection
Cardiology
NEW YORK (Reuters Health) – Individuals infected with HIV face an increased risk of sudden cardiac death (SCD), according to findings published in the May 22nd Journal of…
The month after ACS risky for patients with HIV
Cardiology
NEW YORK (Reuters Health) – Patients with HIV infection who are admitted to the hospital with acute coronary syndrome (ACS) face a “substantial” risk of dying in the…
Benefit of rituximab-EPOCH for HIV-related lymphoma confirmed
HIV/AIDS
NEW YORK (Reuters Health) – A pooled analysis of two trials indicates that HIV patients with aggressive B-cell non-Hodgkin lymphoma (NHL) fare better with a regimen of rituximab…
“Tail” regimens reduce viral resistance after intrapartum nevirapine in HIV-positive women
HIV/AIDS
NEW YORK (Reuters Health) – In pregnant HIV-infected women treated with a single intrapartum dose of nevirapine (NVP) to prevent vertical HIV transmission, the subsequent selection of nevirapine-resistant…